James Culverwell

Mr Culverwell was for 25 years a leading healthcare investment analyst, formerly SVP and Global Coordinator Healthcare at Merrill Lynch. He has been a non-executive director in early stage life science companies, including NASDAQ and AIM listed, and is currently Chairman of HOX Therapeutics.